1,305
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Molecular targeted therapy in acute myeloid leukemia

&
Pages s59-s62 | Published online: 12 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xavier Thomas. (2015) Novel approaches to pediatric leukemia treatment. Expert Review of Anticancer Therapy 15:7, pages 811-828.
Read now
Jessica K. Altman, Amy K. Szilard & Leonidas C. Platanias. (2013) Tyrosine kinase inhibition in acute myeloid leukemia. Leukemia & Lymphoma 54:7, pages 1351-1352.
Read now

Articles from other publishers (20)

Ernesto Rojas-Jiménez, Javier César Mejía-Gómez, Clara Díaz-Velásquez, Rosalía Quezada-Urban, Héctor Martínez Gregorio, Fernando Vallejo-Lecuona, Aldo de la Cruz-Montoya, Fany Iris Porras Reyes, Víctor Manuel Pérez-Sánchez, Héctor Aquiles Maldonado-Martínez, Maybelline Robles-Estrada, Enrique Bargalló-Rocha, Paula Cabrera-Galeana, Maritza Ramos-Ramírez, Yolanda Irasema Chirino, Luis Alonso Herrera, Luis Ignacio Terrazas, Javier Oliver, Cecilia Frecha, Sandra Perdomo & Felipe Vaca-Paniagua. (2020) Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative Breast Cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic. Genes 11:11, pages 1367.
Crossref
Ling-Yun Dai, Chun-Hou Zheng, Jin-Xing Liu, Rong Zhu, Sha-Sha Yuan, Juan Wang & Xiang-Zhen Kong. (2019) Integrative graph regularized matrix factorization for drug-pathway associations analysis. Computational Biology and Chemistry 78, pages 474-480.
Crossref
Joaquin J. Jimenez, Gina M. DelCanto, Petra Popovics, Aymee Perez, Ailin Vila Granda, Irving Vidaurre, Ren-Zhi Cai, Ferenc G. Rick, Ronan T. Swords & Andrew V. Schally. (2018) A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone. British Journal of Haematology 181:4, pages 476-485.
Crossref
Melissa García-Caballero, Beatríz Martínez-Poveda, Miguel A. Medina & Ana R. Quesada. (2017) The Natural Antiangiogenic Compound AD0157 Induces Caspase-Dependent Apoptosis in Human Myeloid Leukemia Cells. Frontiers in Pharmacology 8.
Crossref
Emilee Senkevitch & Scott Durum. (2017) The promise of Janus kinase inhibitors in the treatment of hematological malignancies. Cytokine 98, pages 33-41.
Crossref
Ramon Andrade Bezerra De-Mello, Carlos Pinho-Vaz, Rosa Branca, Fernando Campilho, Maria Rosales, Susana Roncon & António Campos-Júnior. (2016) Outcomes of allogeneic stem cell transplantation among patients with acute myeloid leukemia presenting active disease: Experience of a single European Comprehensive Cancer Center. Revista da Associação Médica Brasileira 62:7, pages 641-646.
Crossref
SHENGHAO WU, CUIPING ZHENG, SONGYAN CHEN, XIAOPING CAI, YUEJIAN SHI, BIJING LIN & YUEMIAO CHEN. (2015) Overexpression of long non-coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia. Oncology Letters 10:4, pages 2410-2414.
Crossref
Lingbo Wang, Weili Cai, Wei Zhang, Xueying Chen, Wenqian Dong, Dongqi Tang, Yun Zhang, Chunyan Ji & Mingxiang Zhang. (2015) Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene. Oncotarget 6:29, pages 27490-27504.
Crossref
Colleen E. Annesley & Patrick Brown. (2015) Novel agents for the treatment of childhood acute leukemia. Therapeutic Advances in Hematology 6:2, pages 61-79.
Crossref
Xuening Wang, Stella Pesakhov, Jonathan S Harrison, Michael Kafka, Michael Danilenko & George P Studzinski. (2015) The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage. Experimental Cell Research 330:1, pages 199-211.
Crossref
Caroline Engen, Line Wergeland, Jørn Skavland & Bjørn Gjertsen. (2014) Targeted Therapy of FLT3 in Treatment of AML—Current Status and Future Directions. Journal of Clinical Medicine 3:4, pages 1466-1489.
Crossref
Clay Smith, Maura Gasparetto, Keith Humphries, Daniel A. Pollyea, Vasilis Vasiliou & Craig T. Jordan. (2014) Aldehyde dehydrogenases in acute myeloid leukemia. Annals of the New York Academy of Sciences 1310:1, pages 58-68.
Crossref
Sook Wah Yee, Joel A Mefford, Natasha Singh, Mary-Elizabeth Percival, Adrian Stecula, Kuo Yang, John S Witte, Atsushi Takahashi, Michiaki Kubo, Koichi Matsuda, Kathleen M Giacomini & Charalambos Andreadis. (2013) Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia. Journal of Human Genetics 58:6, pages 353-361.
Crossref
Yan Xing & Donna E. Hogge. (2013) Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors. Leukemia Research 37:6, pages 697-704.
Crossref
Jerzy Hołowiecki & Aleksandra Hołowiecka. (2013) Leczenie celowane w ostrych białaczkach szpikowych. Acta Haematologica Polonica 44:2, pages 85-92.
Crossref
Mark Wunderlich, Benjamin Mizukawa, Fu-Sheng Chou, Christina Sexton, Mahesh Shrestha, Yogen Saunthararajah & James C. Mulloy. (2013) AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. Blood 121:12, pages e90-e97.
Crossref
Panagiotis Ntziachristos, Jasper Mullenders, Thomas Trimarchi & Iannis Aifantis. 2013. 1 38 .
Harald Herrmann, Katharina Blatt, Junwei Shi, Karoline V. Gleixner, Sabine Cerny-Reiterer, Leonhard Müllauer, Christopher R. Vakoc, Wolfgang R. Sperr, Hans-Peter Horny, James E. Bradner, Johannes Zuber & Peter Valent. (2012) Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML). Oncotarget 3:12, pages 1588-1599.
Crossref
Ngoc Ho, Adam Li, Shaoguang Li & Haojian Zhang. (2012) Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies. Pharmaceuticals 5:8, pages 779-801.
Crossref
Massimo SantoroFrancesca CarlomagnoRosa Marina Melillo. (2012) RET: A Multi-Faceted Gene in Human Cancer. Endocrinology and Metabolism 27:3, pages 173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.